Basic Information
Basic information for MIR646HG-229-16aa
Peptide Name MIR646HG-229-16aa
Genome Position chr20:60126404-60126451[+]
Species Human
Peptide Sequence MLTSTPIERVQVSISE
Peptide Length 16
Unique No (MIR646HG-213-16aa-2,MIR646HG-215-16aa,MIR646HG-217-16aa-1,MIR646HG-222-16aa,MIR646HG-234-16aa,MIR646HG-246-16aa-2,MIR646HG-253-16aa-1,MIR646HG-254-16aa)
Grand Average of Hydropathicity 0.1688
Relative Molecular Mass 2060.35
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000228340;MIR646HG
Transcript ID/Name ENST00000656658;MIR646HG-229
Transcript Length 1502
Coding Ability 0.3123
DNA Sequence Corresponding to Peptide ATGCTCACCTCCACCCCAATAGAAAGGGTCCAGGTATCCATCTCTGAG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :